Synthesis 2011(7): 1113-1119  
DOI: 10.1055/s-0030-1258464
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of (±)-8-Oxa-3-azabicyclo[3.2.1]octan-2-thione and (±)-2-Oxa-5-azabicyclo[2.2.1]heptan-6-thione: Potential Synthons for the Preparation of Novel Heteroaryl-Annulated Bicyclic Morpholines

Daniel P. Walker*, Donn G. Wishka, Paul Beagley, Gemma Turner, Nicola Solesbury
Pfizer Global Research & Development, Eastern Point Road, Groton, CT 06340, USA
Fax: +1(860)6860013; e-Mail: daniel.p.walker@pfizer.com;
Further Information

Publication History

Received 13 December 2010
Publication Date:
08 March 2011 (online)

Abstract

The bridged bicyclic morpholinethiones (±)-8-oxa-3-azabicyclo[3.2.1]octane-2-thione and (±)-2-oxa-5-azabicyclo[2.2.1]heptane-6-thione have been prepared in five and eight steps, respectively. Both compounds were derived from a respective requisite cis-disubstituted tetrahydrofuran, which was stereoselectively prepared via hydrogenation of the corresponding disubstituted furan derivatives.

    References

  • 1 Brickner SJ. Barbachyn MR. Hutchinson DK. Manninen PR. J. Med. Chem.  2008,  51:  1981 
  • 2 Barker AJ. Gibson KH. Grundy W. Godfrey AA. Barlow JJ. Healy MP. Woodburn JR. Ashton SE. Curry BJ. Scarlett L. Henthorn L. Richards L. Bioorg. Med. Chem. Lett.  2001,  1911 
  • 3 Kasper S. El Giamal N. Hilger E. Exp. Opin. Pharmacother.  2000,  1:  771 
  • 4a Abe T, Matsunaga H, Mihira A, Sato C, Ushirogochi H, Sato K, Takasaki T, Venkatesan AM, and Mansour TS. inventors; Patent Cooperation Treaty WO  2003/093277.  ; Chem. Abstr. 2003, 139, 381300
  • 4b Tabei K. Feng X. Venkatesan AM. Abe T. Hideki U. Mansour TS. Siegel MM. J. Med. Chem.  2004,  47:  3674 
  • 4c Petersen PJ. Jones CH. Venkatesan AM. Bradford PA. Antimicrob. Agents Chemother.  2009,  53:  1698 
  • 5 Vasiliou S. Vicente M. Castaner R. Drugs Future  2009,  34:  451 
  • 6 Munk SA. Harcourt D. Ambrus G. Denys L. Gluchowski C. Burke JA. Kharlamb AB. Manlapaz CA. Padillo EU. Runde E. Williams L. Wheeler LA. Garst ME. J. Med. Chem.  1996,  39:  3533 
  • 7a Griffin RJ. Fontana G. Golding BT. Guiard S. Hardcastle IR. Leahy JJJ. Martin N. Richardson C. Rigoreau L. Stockley M. Smith GCM. J. Med. Chem.  2005,  48:  569 
  • 7b Blizzard TB. DiNinno F. Morgan JD. Chen HY. Wu JY. Gude C. Kim S. Chan W. Birzin ET. Yang YT. Pai L.-Y. Zhang Z. Hayes EC. DaSilva CA. Tang W. Rohrer SP. Schaeffer JM. Hammond ML. Bioorg. Med. Chem. Lett.  2004,  3861 
  • 7c Roecker AJ. Coleman PJ. Mercer SP. Schreier SD. Buser CA. Walsh ES. Hamilton K. Lobell RB. Tao W. Diehl RE. South VJ. Davide JP. Kohl NE. Yan Y. Kuo LC. Li C. Fernandez-Metzler C. Mahan EA. Prueksaritanont T. Hartman GD. Bioorg. Med. Chem. Lett.  2007,  5677 
  • 7d Venkatesan AM. Chen Z. Santos OD. Dehnhardt C. Santos ED. Ayral-Kaloustian S. Mallon R. Hollander I. Feldberg L. Lucas J. Yu K. Chaudhary I. Mansour TS. Bioorg. Med. Chem. Lett.  2010,  5869 
  • 7e Zask A. Kaplan J. Verheijen JC. Richard DJ. Curran K. Brooijmans N. Bennett EM. Toral-Barza L. Hollander I. Ayral-Kaloustian S. Yu K. J. Med. Chem.  2009,  52:  7942 
  • 8 Jagodzinski TS. Chem. Rev.  2003,  103:  197 
  • 9a Bromidge SM. Arban R. Bertani B. Bison S. Borriello M. Cavanni P. Dal Forno G. Di-Fabio R. Donati D. Fontana S. Gianotti M. Gordon LJ. Granci E. Leslie CP. Moccia L. Pasquarello A. Sortori I. Sava A. Watson JM. Worby A. Zonzini L. Zucchelli V. J. Med. Chem.  2010,  53:  5827 
  • 9b Thurkauf A. Chen X. Zhang S. Gao Y. Kieltyka A. Wasley JWF. Brodbeck R. Greenlee W. Ganguly A. Zhao H. Bioorg. Med. Chem. Lett.  2003,  2921 
  • 9c Weber M. Jager W. Erker T. J. Heterocycl. Chem.  2003,  40:  851 
  • 10 Moore JA. Partain EM. J. Polym. Sci. Polym. Lett. Ed.  1975,  13:  333 
  • See:
  • 11a Moore JA. Kelly JE. Org. Prep. Proced. Int.  1972,  4:  289 
  • 11b Moore JA. Kelly JE. Org. Prep. Proced. Int.  1974,  6:  255 
  • 11c Bradshaw JS. Baxter SL. Lamb JD. Izatt RM. Christensen JJ. J. Am. Chem. Soc.  1981,  103:  1821 
  • 12a Allen RD. Tran HW. Aust. J. Chem.  1984,  34:  1123 
  • 12b Ichihara A. Yamanaka T. Matsumoto T. Bull. Chem. Soc. Jpn.  1965,  38:  1165 
  • 12c Matsumoto T. Ichihara A. Bull. Chem. Soc. Jpn.  1960,  33:  1015 
  • 13 Wolter FE. Schneider K. Davies BP. Socher ER. Nicholson G. Seitz O. Sussmuth RD. Org. Lett.  2009,  11:  2804 
  • 14 Lee GCM. Holmes JM. Harcourt DA. Garst ME. J. Org. Chem.  1992,  57:  3126 
  • 15 Bergmeier SC. Cobas AA. Rapoport H. J. Org. Chem.  1993,  58:  2369 
  • 16a Nagashima H. Ozaki N. Washiyama M. Itoh K. Tetrahedron Lett.  1985,  26:  657 
  • 16b Ji S. Gortler LB. Waring A. Battisti A. Bank S. Closson WD. J. Am. Chem. Soc.  1967,  89:  5311 
  • 17 Milne HB. Peng C.-H. J. Am. Chem. Soc.  1957,  79:  639 
  • A related heterocycle, isoquinuclidinone, has been prepared via thermal cyclization of cis-4-aminocyclohexane-carboxylic acid in Dowtherm A, see:
  • 18a Pearlman WM. Org. Syn.  1969,  49:  75 
  • 18b Chung JYL. Ho G.-J. Synth. Commun.  2002,  32:  1985 
  • See:
  • 19a Werner LH. Ricca S. J. Am. Chem. Soc.  1958,  80:  2733 
  • 19b Casabona D. Cativiela C. Tetrahedron  2006,  62:  10000 
  • 19c Gong L. Hogg JH. Collier J. Wilhelm RS. Soderberg C. Bioorg. Med. Chem. Lett.  2003,  3597 
  • 20 DCC has been used to effect lactamization on a related carbocyclic system, see: Grunewald GL. Sall DJ. Monn JA. J. Med. Chem.  1988,  31:  433